Grants for Unrestricted - Federal

This funding opportunity is designed for partners within the Californian Cooperative Ecosystem Studies Unit to support research on climate-driven range shifts by providing training, facilitating workshops, and conducting data synthesis efforts.

U.S. Embassy Bern invites proposals for programs that strengthen cultural ties between the United States and Switzerland or Liechtenstein through cultural and exchange programming that highlights shared values and promotes bilateral cooperation and dialogue. All programs must include an American cultural element, or connection with (a) U.S. expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives. The PDS Small Grants Program is open to applications from Swiss, Liechtenstein, and U.S. organizations and individuals. We especially encourage and will prioritize applications from alumni of U.S. State Department Exchange Programs who are residents of Switzerland or Liechtenstein. Priority Program Areas: 1. Recognizing and countering disinformation and misinformation 2. Diversity, equity, inclusion, and accessibility, with a special focus on: 2.1. Women and girls, in all their diversity, in STEAM fields 2. 2.Increasing visibility, equity, inclusion, and accessibility of underrepresented groups in Switzerland and Liechtenstein, including immigrants, migrants, refugees, and asylees 3. Promoting mobility and knowledge transfer of apprenticeships between Switzerland/Liechtenstein and the United States 4. Strengthening entrepreneurship and economic collaboration between the United States and Switzerland with an emphasis on emerging and women entrepreneurs and business students Participants and Audiences: 1. Swiss and Liechtenstein residents 2. Underrepresented groups 3. Swiss and Liechtenstein youth aged 16 to 25 4. Emerging and established professionals and leaders in the priority program areas mentioned above Applicants should read the full description of the statement, attached here or on our website: https://ch.usembassy.gov/embassy/jobs/proposals/

This Funding Opportunity Announcement (FOA) aligns with DOEs Office of Resource Sustainabilitys Methane Emissions Mitigation and Quantification Program to minimize emissions of methane during production, processing, and transportation across the oil and natural gas industry, with the goal of eliminating methane emissions from carbon-based fuel supply chains by 2030. Effective methane emissions mitigation strategies are dependent upon accurate quantification of both intentional and fugitive emissions from all elements across the natural gas infrastructure, including low producing oil and gas wells. Therefore, there is a continual need to maintain a state-of-the-industry understanding methane emissions mitigation opportunities and operation performance, through collection of empirical data, across oil and natural gas production and delivery regions of the United States. This is to maximize the value of these efforts to the public with the goals of reducing GHG emissions and improving environmental health and engagement of the affected public, (largely in disadvantaged or frontline communities). The FOA objective is to make funds available to a variety of entities for the purpose of mitigating methane emissions from marginal conventional wells (MCWs) and other oil and natural gas assets; accelerating the commercialization, scale-up and application of innovative methane emissions reduction technologies; and advancing the characterization and reduction of methane emissions through multi-scale, measurement-informed data collection and analysis. Modification 000001 is issued to update Section I.B. of the FOA to include clarifications regarding: Objectives and Background under AOI 3b; Activities Not of Interest under AOI 1 (1a, 1b, and 1c) and AOI 3 (3a and 3b); and well site and field test location as it relates to AOI 2 (2a, 2b, and 2c)

This grant provides funding to civil society organizations and non-governmental groups in Uganda to strengthen media, promote civic education, and engage youth in governance processes.

This grant provides funding to organizations working in the Eastern and Southern Caribbean to develop programs that help youth avoid gang involvement and related violence through community support, education, and rehabilitation initiatives.

This funding opportunity is designed for partners affiliated with the Colorado Plateau Cooperative Ecosystem Studies Unit to conduct research on drought conditions and sagebrush habitat resilience in dryland ecosystems.

The "Carbon Capture, Removal, and Conversion Test Centers" grant from the U.S. Department of Energy aims to fund the establishment and expansion of test centers for developing and commercializing technologies that capture, remove, and convert carbon dioxide emissions from large sources like power plants and industrial facilities, in an effort to achieve a carbon-free power sector by 2035 and a net-zero greenhouse gas economy by 2050.

This grant invites organizations and companies to collaborate on innovative health solutions aimed at reducing disease and mortality rates in low-and-middle-income countries.

This grant provides funding to the American Association of State Highway Transportation Officials to promote innovative practices in highway and transportation programs across the United States.

USAID Vietnam intends to issue a Cooperative Agreement for USAID/ Vietnam's Combating Illegal Wildlife Trafficking activity. The anticipated dollar range for the five-year activity is between $14 and $16 million. Attached is the draft Program Description (PD) of the activity. We invite your comments/feedback to this draft PD. Any responses should be submitted to Ms. Huyen Dang at [email protected] not later than 9:00 Hanoi time, November 23, 2020 and all responses will be considered prior to finalizing the PD. Please be advised that this is not a Request for Applications (RFA) and does not constitute a commitment on the part of the US. Government to make an award. We anticipate releasing the Request for Applications (RFA) at the end of November, 2020 with a closing date for receipt of applications in mid-January of 2021. We look forward to receiving your comments/feedback. Thank you very much for your time and interest in the activity.

This funding opportunity is designed for research institutions affiliated with the Southern Appalachian Mountains CESU to study climate adaptation in oak-dominated ecosystems and their impact on wildlife, with a focus on species distribution and resource management.

The FY24 ALSRP Pilot Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ALS. Projects may range from phase 1 to small-scale phase 2 trials and should aim to de-risk and inform the design of more advanced trials by investigating safety, feasibility, biomarker application, and therapeutic efficacy in relevant patient populations. Clinical trials may be designed to evaluate promising drugs, biologics, or devices with anticipated therapeutic impact that is supported by strong scientific rationale and existing preliminary studies and/or preclinical data. Clinical trials aimed to improve aspects of patient care and ALS symptom management are also applicable to this award mechanism.Funding from this award mechanism must support a clinical trial. A clinical trial is defined as a research study in which one or more study participants are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. For more information, a Human Subject Resource Document is provided at https://cdmrp.health.mil/pubs/pdf/Human%20Subjects%20Resource%20Document_DEC2022.pdf. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other FY24 ALSRP program announcements being offered. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Projects proposing a therapeutic intervention (drug, biologic, and/or device) must incorporate biomarkers specific to the intervention into the trial design. Applicants must clearly describe a biomarker-driven approach and its potential to de-risk and improve the design of anticipated later-stage trials. For further description, see Attachment 13, Biomarker Statement. Biomarker development and characterization can include target engagement biomarkers, pharmacodynamic biomarkers to measure the biological effect of an investigational therapeutic, and/or predictive/cohort-selective biomarkers that indicate whether a specific therapy will be effective in an individual patient or patient subgroup.Key aspects of the FY24 ALSRP Pilot Clinical Trial Award mechanism include:Impact: Potential impact from a pilot clinical trial is not whether an intervention is ready at the conclusion of the trial, but rather if the outcomes will improve and accelerate future larger trials or clinical care and symptom management. Applications submitted to this award can have outcomes that focus on specific subpopulations of ALS patients or potentially even individual patients.Biomarker-Driven Interventions: Therapeutic outcomes should directly and substantially de-risk and inform the design of anticipated later-phase trials of the intervention under investigation.Clinical Care: Improving aspects of clinical care and symptom management should have near-term impact on patients. All interventions must offer significant potential impact for individuals affected by ALS; however, this may include just specific subpopulations or potentially even individual patients.Employing Community Collaborations to Optimize Research Impact Is Required. Research funded by the FY24 ALSRP Pilot Clinical Trial Award should be responsive to the needs of people with ALS, their families, and/or their care partners. Research teams are therefore required to establish and utilize effective and equitable collaborations and partnerships with Community members to maximize impact potential of the proposed research. These collaborations are expected to facilitate accessible, efficient, and humane clinical trials. Applications to the FY24 ALSRP Pilot Clinical Trial Award must name at least one Community partner (e.g., person with ALS, family member and/or caregiver, representative of a community-based organization) who will provide advice and consultation throughout the planning and implementation of the research project. Scientific researchers and Community members will collaborate and contribute equitably on all aspects of the project, which may include needs assessment, planning, research intervention design, implementation, evaluation, and dissemination. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. Examples for implementing collaborative research approaches include:Person Living with ALS, Family Member, and/or Caregiver: The research team includes a person with ALS, their family member, or caregiver (past or present) as a project advisor who will provide advice and consultation throughout the planning and implementation of the research project.Partnership with a Community-Based Organization: The research team establishes partnerships with at least one Community-based organization that provides advice and consultation throughout the planning and implementation of the research project. Community-based organizations may include advocacy groups, service providers, policymakers, or other formal organizational stakeholders.Community Advisory Board: A Community advisory board is composed of multiple Community stakeholders and can take many forms, from a board of people with ALS, their family members, or caregivers to a coalition of Community-based organizations or any combination thereof. As with people living with ALS and organizational partners, the Community advisory board provides advice and consultation throughout planning and implementation of the research project.Clinical Trial Start Date and Intervention Availability: The proposed clinical trial is expected to begin no later than 12 months after the award date or 18 months after the award date for Food and Drug Administration (FDA)-regulated studies. The application should demonstrate the documented availability of and access to the drug/compound, device, and/or other materials needed, as appropriate, for the proposed duration of the study.Study Population: The application should demonstrate the availability of and access to a suitable patient population that will support a meaningful outcome for the study. The application should include a discussion of how accrual goals will be achieved, as well as the strategy for inclusion of women and minorities in the clinical trial appropriate to the objectives of the study.Research Personnel and Environment: The application should demonstrate the study teams expertise and experience in all aspects of conducting clinical trials, including appropriate statistical analysis, knowledge of FDA processes (if applicable), and data management. The application should include a study coordinator(s) who will guide the clinical protocol through the local Institutional Review Board (IRB) of record and other federal agency regulatory approval processes, coordinate activities from all sites participating in the trial, and coordinate participant accrual. The application should show strong institutional support and, if applicable, a commitment to serve as the FDA regulatory sponsor, ensuring all sponsor responsibilities described in the Code of Federal Regulations, Title 21, Part 312 (21 CFR 312), Subpart D, are fulfilled.Statistical Analysis and Data Management Plans: The application should include a clearly articulated statistical analysis plan, a power analysis reflecting sample size projection that will answer the objectives of the study, and a data management plan that includes use of an appropriate database to safeguard and maintain the integrity of the data. If FDA-regulated, the trial must use a 21 CFR 11-compliant database and appropriate data standards. For more on data standards, see https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/ FormsSubmissionRequirements/ElectronicSubmissions/UCM511237.pdf.Transition Plan: Applications should include a transition plan (including potential funding and resources) showing how the intervention will progress to the next clinical trial phase and/or improve current standards of care after the successful completion of the FY24 ALSRP Pilot Clinical Trial Award.Milestone meeting: The Principal Investigator (PI) will be required to present an update on progress toward accomplishing the goals of the award at annual, virtual In Progress Review meetings to be held during the period of performance. The PI should ideally include their Community collaboration partner(s) in the meeting. The In Progress Review Meeting will be attended by members of the ALSRP Programmatic Panel, CDMRP staff, the USAMRAA Grants/Contracts Officer, and other stakeholders.

This program seeks to strengthen citizen trust in Kenya's electoral processes by supporting the government, civil society, and other stakeholders in ensuring free, fair, and peaceful elections during the 2027 electoral cycle.

United States Agency for International Development (USAID) Mozambique is planning the Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANA) Activity, focused on improving health outcomes of households vulnerable to and impacted by HIV in Manica, Tete and Sofala.

This funding opportunity provides financial support for training facilitators who conduct victim-offender dialogues, aimed at improving post-conviction victim services and promoting restorative justice.

The DoD Arthritis, Focused Research Award is a funding opportunity aimed at supporting innovative, high-risk/high-reward arthritis research that could lead to significant discoveries or improvements in patient care and quality of life, with a particular emphasis on the impact of arthritis in the military and on women's health.

The "Judicial Tools to Combat Impaired Driving" grant aims to provide training for DWI Court teams and Judges handling impaired driving cases, with the goal of improving court processes and reducing repeat offenses through strategies like individualized sentencing and motivational interviewing.

DE-FOA-0003323: Water Power Innovation Network AMENDMENT 000003: The purpose of this modification is to: Update the Expected Date for EERE Selection Notifications and Expected Timeframe for Award Negotiations. Add clarification to the down-select deliverable, Updated Budget, SOPO, and Project Schedule. Add clear requirements to the Content for the Full Application regarding what information to include for Budget Period 1 versus Budget Period 2. This includes the following changes: The Technical Volume Workplan should include goals, objectives, and anticipated outcomes for each budget period. The Technical Volume Workplan should include a detailed Workplan summary for Budget Period 1 and a preliminary high-level overview for Budget Period 2 of activities to be conducted over Budget Period 2. The Technical Volume Workplan should describe at least one end of project Specific, Measurable, Attainable, Realistic, and Timely (SMART) goal for each budget period. The Technical Volume Workplan should include a summary of appropriate milestones throughout each budget period. For Budget Period 2 milestones, however, it is sufficient to list approximate, reasonable estimates of what the milestones will be. It is understood that Budget Period 2 activities will be progressively developed over the course of Budget Period 1 and as such precise information on Budget Period 2 activities may not be available during the application process. Project applications will not be penalized for having a lower level of detail of Budget Period 2 activities during the application process. Rather, Budget Period 2 activities will be comprehensively evaluated during the down-select process at the end of Budget Period 1. The Technical Volume Workplan should include a detailed schedule for Budget Period 1 and a preliminary high-level/approximate schedule for Budget Period 2. As with the work plan, it is expected that the Budget Period 2 schedule will be developed over the course of Budget Period 1. Project applications will not be penalized for providing a lower level of detail during the application process. Rather, Budget Period 2 schedules will be comprehensively evaluated during the down-select process at the end of Budget Period 1. An updated associated SOPO template is provided. Add clarification to the Budget Justification Workbook for what to include for Budget Period 1 versus Budget Period 2. Update the Technical Review Criteria, Criterion 3: Workplan, to be consistent with the updates to the Technical Volume and associated SOPO. AMENDMENT 000002: The purpose of this modification is to provide clarity to the following areas and update the Statement of Project Objectives template: Added language that clarifies the proposed programming and services will be further developed during Budget Period 1. Added language that applicants proposed programs should provide incubation, acceleration, and commercialization support to entrepreneurs and small businesses in water power. Added language to the Content and Form of the Concept Paper and Full Application that clarifies the proposed program could be a new water power incubator or accelerator program, or could be an existing incubator or accelerator program that will be expanded upon in water power. Technical Volume Work Plan to focus on Budget Period 1. An associated SOPO template is provided. The Down-Select deliverable, Updated Budget, SOPO, and Project Schedule, should be updated to include information for Budget Period 2. AMENDMENT 000001: The purpose of this modification is to adjust the timeline for this FOA, which includes changes to the following dates: Submission Deadline for Concept Papers Submission Deadline for Full Applications Expected Date for EERE Selection Notifications Expected Timeframe for Award Negotiations The U.S. Department of Energys (DOE) Water Power Technologies Office (WPTO) is issuing this $4.8 million funding opportunity announcement (FOA) Water Power Innovation Network to support business creation, entrepreneurship, and regional innovation for water power systems and solutions. WPTO enables research, development, and testing of emerging technologies to advance marine energy as well as next-generation hydropower and pumped storage systems for a flexible, reliable grid. Through this FOA, WPTO seeks to fund new and/or expanded incubator or accelerator programs that enable entrepreneurship and accelerate water power innovation, business creation, and growth in communities and regions throughout the United States. Through this FOA, new and/or expanded incubators and accelerators in water power will be able to collaborate with one another and build a stronger water power innovation network in support of accelerating water power technologies to market. Topic Area 1: Water Power Incubation and Acceleration. This topic area will fund programs that accelerate the commercialization and adoption of water power systems and solutions through incubation and acceleration programming and services that support entrepreneurs and small businesses in marine energy and/or hydropower. Questions regarding the FOA must be submitted to [email protected]. To view the entire FOA document, visit the EERE Exchange Website at https://eere-exchange.energy.gov.

This funding opportunity provides financial support to organizations working to reduce plastic pollution in Vietnam through innovative waste management practices, policy development, and community engagement.

This funding opportunity supports community-based arts programs designed to enhance the health and well-being of military personnel, veterans, and their families through creative engagement.